Latest Breaking News On - Immunology research - Page 1 : vimarsana.com

Expert Panel Review Further Validates Use of ZORYVE® (roflumilast) Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis Across Diverse Hair Types Published in Journal of Clinical and Aesthetic Dermatology

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts

Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024

Novel cell therapy treatments offer promise to immune-compromised children

WASHINGTON, April 18, 2024 (GLOBE NEWSWIRE) -- In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from vir...

Novel cell therapy treatments offer promise to immune-compromised children

Novel cell therapy treatments offer promise to immune-compromised children

Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment

Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, described monitoring protocols for clinicians when using oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).

Raj Chovatiya, MD, PhD: Takeaways from New Data on Vitiligo, Atopic Dermatitis, HS Treatments

This post-AAD interview with Chovatiya covered takeaways regarding recent data on upadacitinib for vitiligo, tapinarof for eczema, and lutikizumab for hidradenitis suppurativa.

Reflecting on Latest Updates in Psoriasis Research with Raj Chovatiya, MD, PhD

Chovatiya spoke in this post-AAD interview to some of the major takeaways in psoriasis research, highlighting deucravacitinib, bimekizumab, and other therapies.

Foods for mitigating allergies

Q. My seasonal allergies always get bad this time of year. Are there any foods I can eat or avoid to help ease my allergy symptoms?